| Oct 25 |
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
|
| Oct 24 |
OTC Markets Hosts Virtual Investor Presentation with Dror Bashan, President & CEO of Protalix Biotherapeutics, and John Vandermosten, Senior Analyst at Zacks SCR
|
| Sep 20 |
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
|
| Sep 16 |
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
|
| Sep 16 |
Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024
|
| Sep 4 |
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Sep 3 |
Protalix stock jumps 11% on promissory note repayment
|
| Sep 3 |
Protalix BioTherapeutics Announces Repayment of Outstanding Senior Secured Convertible Promissory Notes
|
| Aug 30 |
Is Protalix BioTherapeutics, Inc. (PLX) The Best Rated Penny Stock To Buy According to Analysts?
|
| Aug 22 |
PLX: A Focus on Renal Rare Disease
|
